Infectious Disease Book

http://www.fpnotebook.com/

Pyrimethamine sulfadoxine

Aka: Pyrimethamine sulfadoxine, Fansidar, Daraprim
  1. Indications: Malaria Prophylaxis and Treatment
    1. Areas with Chloroquine resistance
    2. Not recommended for routine prophylaxis
    3. Treatment in breakthrough Chloroquine Resistance
  2. Preparations
    1. Tablet: 25/500
  3. Directions
    1. Taking with food decreases gastric irritation
  4. Dosing: Prophylaxis
    1. Child
      1. Age 2-11 months: 1/8 tablet PO each week
      2. Age 1-3 years: 1/4 tablet PO each week
      3. Age 4-8 years: 1/2 tablet PO each week
      4. Age 9-14 years: 3/4 tablet PO each week
    2. Adolescent (over age 14 years): 1 tablet PO each week
    3. Adult: 25/500 mg tablet PO each week
  5. Dosing: Treatment
    1. Adult: 75/1500 mg for 1 dose
    2. Child: Double dose of prophylactic dose

Daraprim (C0591326)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH D011739
English Daraprim, Glaxo Wellcome Brand of Pyrimethamine, GlaxoSmithKline Brand of Pyrimethamine, Wellcome Brand of Pyrimethamine
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Pyrimethamine / Sulfadoxine (C0700599)

Definition (NCI) A combination product containing pyrimethamine and sulfadoxine. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. Sulfadoxine competitively antagonizes paraaminobenzoic acid (PABA), resulting in disruption of folic acid synthesis and ultimately DNA synthesis. Sulfadoxine acts synergistically with pyrimethamine. (NCI04)
Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C001205
SnomedCT 398770008, 53357005
English pyrimethamine-sulfadoxine, Pyrimethamine with sulfadoxine, Pyrimethamine-sulfadoxine, sulfadoxine-pyrimethamine, sulphadoxine-pyrimethamine, PYRIMETHAMINE/SULFADOXINE, Pyrimethamine + sulphadoxine, sulfadoxine + pyrimethamine, sulfadoxine + pyrimethamine (medication), Pyrimethamine + Sulphadoxine, Pyrimethamine + Sulfadoxine, Pyrimethamine / Sulfadoxine, Pyrimethamine + sulfadoxine (product), Pyrimethamine + sulfadoxine, pyrimethamine sulfadoxine, Pyrimethamine with sulfadoxine (substance), Pyrimethamine with sulphadoxine, Pyrimethamine-sulphadoxine, Pyrimethamine Sulfadoxine, Pyrimethamine-Sulfadoxine, Sulfadoxine and Pyrimethamine
Spanish pirimetamina + sulfadoxina (producto), pirimetamina + sulfadoxina, pirimetamina con sulfadoxina, pirimetamina-sulfadoxina (sustancia), pirimetamina-sulfadoxina
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Fansidar (C0060061)

Concepts Organic Chemical (T109) , Pharmacologic Substance (T121)
MSH C001205
English Fansidar, fansidar
Sources
Derived from the NIH UMLS (Unified Medical Language System)


Navigation Tree